Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 432685, 6 pages
http://dx.doi.org/10.1155/2014/432685
Review Article

The Role of Inflammation in the Pathogenesis of Macular Edema Secondary to Retinal Vascular Diseases

1Department of Ophthalmology, “Lozano Blesa” University Clinic Hospital, San Juan Bosco 15, 50009 Zaragoza, Spain
2Aragon Health Sciences Institute, Zaragoza, Spain
3Department of Ophthalmology, University Hospital Arnau de Vilanova, Lleida, Spain
4IRB-Lleida, Lleida, Spain
5Department of Ophthalmology, Poznań City Hospital, Poznań, Poland
6University of Warmia and Mazury, Olsztyn, Poland

Received 10 May 2014; Revised 5 July 2014; Accepted 9 July 2014; Published 22 July 2014

Academic Editor: Yves Denizot

Copyright © 2014 Francisco J. Ascaso et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Scholl, J. Kirchhof, and A. J. Augustin, “Pathophysiology of macular edema,” Ophthalmologica, vol. 224, supplement 1, pp. 8–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Marmor, “Mechanisms of fluid accumulation in retinal edema,” Documenta Ophthalmologica, vol. 97, no. 3-4, pp. 239–249, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. P. G. Tranos, S. S. Wickremasinghe, N. T. Stangos, F. Topouzis, I. Tsinopoulos, and C. E. Pavesio, “Macular edema,” Survey of Ophthalmology, vol. 49, no. 5, pp. 470–490, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kaštelan, V. Zjačić-Rotkvić, and Ž. Kaštelan, “Could diabetic retinopathy be an autoimmune disease?” Medical Hypotheses, vol. 68, no. 5, pp. 1016–1018, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Adamis and A. J. Berman, “Immunological mechanisms in the pathogenesis of diabetic retinopathy,” Seminars in Immunopathology, vol. 30, no. 2, pp. 65–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. P. Park and J. K. Ahn, “Changes of aqueous vascular endothelial growth factor and interleukin-6 after intravitreal triamcinolone for branch retinal vein occlusion,” Clinical & Experimental Ophthalmology, vol. 36, no. 9, pp. 831–835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Vinores, N. L. Derevjanik, H. Ozaki, N. Okamoto, and P. A. Campochiaro, “Cellular mechanisms of blood-retinal barrier dysfunction in macular edema,” Documenta Ophthalmologica, vol. 97, no. 3-4, pp. 217–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. D. A. Antonetti, E. Lieth, A. J. Barber, and T. W. Gardner, “Molecular mechanisms of vascular permeability in diabetic retinopathy,” Seminars in Ophthalmology, vol. 14, no. 4, pp. 240–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Romero-Aroca, “Targeting the pathophysiology of diabetic macular edema,” Diabetes Care, vol. 33, no. 11, pp. 2484–2485, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Joussen, N. Smyth, and C. Niessen, “Pathophysiology of diabetic macular edema,” Developments in Ophthalmology, vol. 39, pp. 1–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Fekrat and D. Finkelstein, “Venous occlusive disease,” in Vitreoretinal Disease: The Essentials, C. D. Regillo, G. C. Brown, and H. W. Flynn Jr., Eds., chapter 9, pp. 117–132, Thieme, New York, NY, USA, 1999. View at Google Scholar
  12. F. J. Ascaso and V. Huerva, “Vitreoretinal traction in impending branch retinal vein occlusion: a pathogenetic role?” Thrombosis and Haemostasis, vol. 108, no. 2, pp. 208–209, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. J. Ascaso, E. Padgett, E. Núñez, L. Villén, A. Grzybowski, and J. A. Cristóbal, “Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case–control study,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 252, no. 3, pp. 375–381, 2014. View at Google Scholar
  14. S. A. Huber, P. Sakkinen, D. Conze, N. Hardin, and R. Tracy, “Interleukin-6 exacerbates early atherosclerosis in mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 10, pp. 2364–2367, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. L. J. Pinderski, M. P. Fischbein, G. Subbanagounder et al., “Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes,” Circulation Research, vol. 90, no. 10, pp. 1064–1071, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. S. C. Whitman, P. Ravisankar, H. Elam, and A. Daugherty, “Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E-/- mice,” The American Journal of Pathology, vol. 157, no. 6, pp. 1819–1824, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. M. Silva, J. R. Faria de Abreu, and J. G. Cunha-Vaz, “Blood-retina barrier in acute retinal branch vein occlusion,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 233, no. 11, pp. 721–726, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. L. P. Aiello, J. M. Northrup, B. A. Keyt, H. Takagi, and M. A. Iwamoto, “Hypoxic regulation of vascular endothelial growth factor in retinal cells,” Archives of Ophthalmology, vol. 113, no. 12, pp. 1538–1544, 1995. View at Publisher · View at Google Scholar · View at Scopus
  19. W. J. Lee, M. H. Kang, M. Seong, and H. Y. Cho, “Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion,” British Journal of Ophthalmology, vol. 96, no. 11, pp. 1426–1430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Vinores, A. I. Youssri, J. D. Luna et al., “Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease,” Histology and Histopathology, vol. 12, no. 1, pp. 99–109, 1997. View at Google Scholar · View at Scopus
  21. A. M. Joussen, N. Smyth, and C. Niessen, “Pathophysiology of diabetic macular edema,” Developments in Ophthalmology, vol. 39, pp. 1–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Pasqualetti, R. Danesi, M. del Tacca, and G. Bocci, “Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy,” Pharmacogenomics, vol. 8, no. 1, pp. 49–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yoshimura, K. Sonoda, M. Sugahara et al., “Comprehensive analysis of inflammatory immune mediators in vitreoretinal diseases,” PLoS ONE, vol. 4, no. 12, Article ID e8158, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Ogino, T. Murakami, A. Tsujikawa et al., “Characteristics of optical coherence tomographic hyperreflective foci in retinal vein occlusion,” Retina, vol. 32, no. 1, pp. 77–85, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Noma, H. Funatsu, M. Yamasaki et al., “Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6,” American Journal of Ophthalmology, vol. 140, no. 2, pp. 256.e1–256.e7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Noma, A. Minamoto, H. Funatsu et al., “Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 3, pp. 309–315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Shimura, T. Nakazawa, K. Yasuda et al., “Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema,” American Journal of Ophthalmology, vol. 145, no. 5, pp. 854–861, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Kunikata, M. Shimura, T. Nakazawa et al., “Chemokines in aqueous humour before and after intravitreal triamcinolone acetonide in eyes with macular oedema associated with branch retinal vein occlusion,” Acta Ophthalmologica, vol. 90, no. 2, pp. 162–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Funatsu, H. Noma, T. Mimura, S. Eguchi, and S. Hori, “Association of vitreous inflammatory factors with diabetic macular edema,” Ophthalmology, vol. 116, no. 1, pp. 73–79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Noma, H. Funatsu, M. Yamasaki et al., “Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion,” Eye, vol. 22, no. 1, pp. 42–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Funatsu, H. Noma, T. Mimura, and S. Eguchi, “Vitreous inflammatory factors and macular oedema,” British Journal of Ophthalmology, vol. 96, no. 2, pp. 302–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Noma, H. Funatsu, T. Mimura, S. Harino, and S. Hori, “Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion,” Ophthalmology, vol. 116, no. 1, pp. 87–93, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Struyf, P. Proost, and J. van Damme, “Regulation of the immune response by the interaction of chemokines and proteases,” Advances in Immunology, vol. 81, pp. 1–44, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. A. M. Abu El-Asrar, S. Struyf, D. Kangave, K. Geboes, and J. van Damme, “Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy,” European Cytokine Network, vol. 17, no. 3, pp. 155–165, 2006. View at Google Scholar · View at Scopus
  35. M. Funk, K. Kriechbaum, F. Prager et al., “Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab,” Investigative Ophthalmology and Visual Science, vol. 50, no. 3, pp. 1025–1032, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Ai and H. P. Song, “Different expression pattern of serum soluble intercellular adhesion molecules-1 and neutrophilic expression of CD18 in patients with diabetic retinopathy,” International Journal of Ophthalmology, vol. 5, pp. 202–207, 2012. View at Google Scholar
  37. H. Huang, J. K. Gandhi, X. Zhong et al., “TNFα is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis,” Investigative Ophthalmology and Visual Science, vol. 52, no. 3, pp. 1336–1344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. N. G. Frangogiannis, “Chemokines in the ischemic myocardium: from inflammation to fibrosis,” Inflammation Research, vol. 53, no. 11, pp. 585–595, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. Diabetic Retinopathy Clinical Research Network, “A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema,” Ophthalmology, vol. 114, no. 10, pp. 1860–1867, 2007. View at Google Scholar
  40. H. Noma, H. Funatsu, T. Mimura, and K. Shimada, “Increase of aqueous inflammatory factors in macular edema with branch retinal vein occlusion: a case control study,” Journal of Inflammation, vol. 7, article 44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Nishijima, J. Kiryu, A. Tsujikawa et al., “Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury,” Investigative Ophthalmology and Visual Science, vol. 44, no. 1, pp. 332–341, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. A. M. Jousssen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Google Scholar
  43. S. X. Zhang, J. J. Wang, G. Gao, C. Shao, R. Mott, and J. Ma, “Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor,” The FASEB Journal, vol. 20, no. 2, pp. 323–325, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Bringmann, A. Reichenbach, and P. Wiedemann, “Pathomechanisms of cystoid macular edema,” Ophthalmic Research, vol. 36, no. 5, pp. 241–249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Reichenbach, A. Wurm, T. Pannicke, I. Iandiev, P. Wiedemann, and A. Bringmann, “Müller cells as players in retinal degeneration and edema,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 5, pp. 627–636, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Bringmann and P. Wiedemann, “Müller glial cells in retinal disease,” Ophthalmologica, vol. 227, no. 1, pp. 1–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Bringmann, T. Pannicke, J. Grosche et al., “Müller cells in the healthy and diseased retina,” Progress in Retinal and Eye Research, vol. 25, no. 4, pp. 397–424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. W. D. Stamer, D. Bok, J. Hu, G. J. Jaffe, and B. S. McKay, “Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement,” Investigative Ophthalmology and Visual Science, vol. 44, no. 6, pp. 2803–2808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Iandiev, T. Pannicke, M. B. Reichel, P. Wiedemann, A. Reichenbach, and A. Bringmann, “Expression of aquaporin-1 immunoreactivity by photoreceptor cells in the mouse retina,” Neuroscience Letters, vol. 388, no. 2, pp. 96–99, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. EA. Nagelhus, Y. Horio, and A. Inanobe, “Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains,” Glia, vol. 26, no. 1, pp. 47–54, 1999. View at Publisher · View at Google Scholar
  51. T. Pannicke, I. Iandiev, O. Uckermann et al., “A potassium channel-linked mechanism of glial cell swelling in the postischemic retina,” Molecular and Cellular Neuroscience, vol. 26, no. 4, pp. 493–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Pannicke, I. Iandiev, A. Wurm et al., “Diabetes alters osmotic swelling characteristics and membrane conductance of glial cells in rat retina,” Diabetes, vol. 55, no. 3, pp. 633–639, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Reichenbach and A. Bringmann, Müller Cells in the Healthy and Diseased Retina, Springer, New York, NY, USA, 2010.
  54. A. Bringmann, T. Pannicke, B. Biedermann et al., “Role of retinal glial cells in neurotransmitter uptake and metabolism,” Neurochemistry International, vol. 54, no. 3-4, pp. 143–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Nakazawa, A. Matsubara, K. Noda et al., “Characterization of cytokine responses to retinal detachment in rats,” Molecular Vision, vol. 12, pp. 867–878, 2006. View at Google Scholar · View at Scopus
  56. M. Hollborn, M. Francke, I. Iandiev et al., “Early activation of inflammation- and immune response-related genes after experimental detachment of the porcine retina,” Investigative Ophthalmology and Visual Science, vol. 49, no. 3, pp. 1262–1273, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. D. G. Puro and E. L. Stuenke, “Thrombin-induced inhibition of potassium currents in human retinal glial (Müller) cells,” The Journal of Physiology, vol. 485, no. 2, pp. 337–348, 1995. View at Google Scholar · View at Scopus
  58. S. Kusaka, N. V. Kapousta-Bruneau, and D. G. Puro, “Plasma-induced changes in the physiology of mammalian retinal glial cells: role of glutamate,” Glia, vol. 25, pp. 205–215, 1999. View at Google Scholar
  59. J. G. Cunha-Vaz and A. Travassos, “Breakdown of the blood-retinal barriers and cystoid macular edema,” Survey of Ophthalmology, vol. 28, pp. S485–S492, 1984. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Tout, T. Chan-Ling, H. Hollander, and J. Stone, “The role of Müller cells in the formation of the blood-retinal barrier,” Neuroscience, vol. 55, no. 1, pp. 291–301, 1993. View at Publisher · View at Google Scholar · View at Scopus
  61. C. M. Diaz, P. L. Penfold, and J. M. Provis, “Modulation of the resistance of a human endothelial cell line by human retinal glia,” Australian and New Zealand Journal of Ophthalmology, vol. 26, no. 1, pp. S62–S64, 1998. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Tretiach, M. C. Madigan, L. Wen, and M. C. Gillies, “Effect of Müller cell co-culture on in vitro permeability of bovine retinal vascular endothelium in normoxic and hypoxic conditions,” Neuroscience Letters, vol. 378, no. 3, pp. 160–165, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. W. Eichler, Y. Yafai, P. Wiedemann, and A. Reichenbach, “Angiogenesis-related factors derived from retinal glial (Müller) cells in hypoxia,” NeuroReport, vol. 15, no. 10, pp. 1633–1637, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. P. J. Keck, S. D. Hauser, G. Krivi et al., “Vascular permeability factor, an endothelial cell mitogen related to PDGF,” Science, vol. 246, no. 4935, pp. 1309–1312, 1989. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Murata, K. Nakagawa, A. Khalil, T. Ishibashi, H. Inomata, and K. Sueishi, “The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas,” Laboratory Investigation, vol. 74, no. 4, pp. 819–825, 1996. View at Google Scholar · View at Scopus
  66. J. D. Luna, C. C. Chan, N. L. Derevjanik et al., “Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor-α, and interleukin-1β-mediated breakdown,” Journal of Neuroscience Research, vol. 49, no. 3, pp. 268–280, 1997. View at Google Scholar
  67. L. P. Aiello, S. E. Bursell, A. Clermont et al., “Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor,” Diabetes, vol. 46, no. 9, pp. 1473–1480, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. L. Claudio, J. A. Martiney, and C. F. Brosnan, “Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1β or tumor necrosis factor-α,” Laboratory Investigation, vol. 70, no. 6, pp. 850–861, 1994. View at Google Scholar · View at Scopus
  69. N. L. Derevjanik, S. A. Vinores, W. Xiao et al., “Quantitative assessment of the integrity of the blood-retinal barrier in mice,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2462–2467, 2002. View at Google Scholar · View at Scopus
  70. K. M. Drescher and J. A. Whittum-Hudson, “Modulation of immune-associated surface markers and cytokine production by murine retinal glial cells,” Journal of Neuroimmunology, vol. 64, no. 1, pp. 71–81, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. R. H. Amin, R. N. Frank, A. Kennedy, D. Eliott, J. E. Puklin, and G. W. Abrams, “Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 38, no. 1, pp. 36–47, 1997. View at Google Scholar · View at Scopus
  72. W. Eichler, H. Kuhrt, S. Hoffmann, P. Wiedemann, and A. Reichenbach, “VEGF release by retinal glia depends on both oxygen and glucose supply,” NeuroReport, vol. 11, no. 16, pp. 3533–3537, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. Y. Yafai, I. Iandiev, P. Wiedemann, A. Reichenbach, and W. Eichler, “Retinal endothelial angiogenic activity: effects of hypoxia and glial (Müller) cells,” Microcirculation, vol. 11, no. 7, pp. 577–586, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. K. Noda, S. Ishida, H. Shinoda et al., “Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells,” Investigative Ophthalmology and Visual Science, vol. 46, no. 10, pp. 3817–3824, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. I. Iandiev, A. Wurm, M. Hollborn et al., “Müller cell response to blue light injury of the rat retina,” Investigative Ophthalmology and Visual Science, vol. 49, no. 8, pp. 3559–3567, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. E. A. Nagelhus, Y. Horio, A. Inanobe et al., “Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains,” Glia, vol. 26, pp. 47–54, 1999. View at Google Scholar
  77. E. A. Nagelhus, M. L. Veruki, R. Torp et al., “Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes,” Journal of Neuroscience, vol. 18, no. 7, pp. 2506–2519, 1998. View at Google Scholar · View at Scopus
  78. I. Iandiev, T. Pannicke, B. Biedermann, P. Wiedemann, A. Reichenbach, and A. Bringmann, “Ischemia-reperfusion alters the immunolocalization of glial aquaporins in rat retina,” Neuroscience Letters, vol. 408, no. 2, pp. 108–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. I. Iandiev, T. Pannicke, A. Reichenbach, P. Wiedemann, and A. Bringmann, “Diabetes alters the localization of glial aquaporins in rat retina,” Neuroscience Letters, vol. 421, no. 2, pp. 132–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Zhao, E. Bousquet, F. Valamanesh et al., “Differential regulations of AQP4 and Kir4.1 by triamcinolone acetonide and dexamethasone in the healthy and inflamed retina,” Investigative Ophthalmology and Visual Science, vol. 52, no. 9, pp. 6340–6347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. M. S. Ip, I. U. Scott, P. C. Van Veldhuisen et al., “A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 5,” Archives of Ophthalmology, vol. 127, no. 9, pp. 1101–1114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. I. L. McAllister, S. Vijayasekaran, S. D. Chen, and D. Yu, “Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion,” American Journal of Ophthalmology, vol. 147, no. 5, pp. 838–846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  83. O. Uckermann, F. Kutzera, A. Wolf et al., “The glucocorticoid triamcinolone acetonide inhibits osmotic swelling of retinal glial cells via stimulation of endogenous adenosine signaling,” Journal of Pharmacology and Experimental Therapeutics, vol. 315, no. 3, pp. 1036–1045, 2005. View at Publisher · View at Google Scholar · View at Scopus
  84. M. Rehak, M. Hollborn, I. Iandiev et al., “Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat,” Investigative Ophthalmology & Visual Science, vol. 50, no. 5, pp. 2359–2367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. R. F. Spaide, L. S. Chang, J. M. Klancnik et al., “Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion,” American Journal of Ophthalmology, vol. 147, no. 2, pp. 298–306, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. P. Thichanpiang, S. J. Harper, K. Wongprasert, and D. O. Bates, “TNF-α-induced ICAM-1 expression and monocyte adhesion in human RPE cells is mediated in part through autocrine VEGF stimulation,” Molecular Vision, vol. 20, pp. 781–789, 2014. View at Google Scholar
  87. L. Paccola, R. A. Costa, M. S. Folgosa, J. C. Barbosa, I. U. Scott, and R. Jorge, “Intravitreal triamcinolone versus bevacizumab for treatment of refractory diabetic macular oedema (IBEME study),” British Journal of Ophthalmology, vol. 92, no. 1, pp. 76–80, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. J. L. Edelman, D. Lutz, and M. R. Castro, “Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown,” Experimental Eye Research, vol. 80, no. 2, pp. 249–258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  89. M. J. Koss, H. Naser, A. Sener et al., “Combination therapy in diabetic macular oedema and retinal vein occlusion—past and present,” Acta Ophthalmologica, vol. 90, no. 6, pp. 580–589, 2012. View at Publisher · View at Google Scholar · View at Scopus